Telix Pharmaceuticals earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TLX earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TLX reported annual earnings of -$4.8M, with -122.8% growth.
Telix Pharmaceuticals Earnings Reports & History FAQ
What were Telix Pharmaceuticals's earnings last quarter?
On TLX's earnings call on Jul 2, 2026, Telix Pharmaceuticals (NASDAQ: TLX) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total TLX earnings for the quarter were N/A. In the same quarter last year, Telix Pharmaceuticals's earnings per share (EPS) was N/A.
Is Telix Pharmaceuticals profitable or losing money?
As of the last Telix Pharmaceuticals earnings report, Telix Pharmaceuticals is currently losing money. Telix Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
What was TLX's earnings growth in the past year?
As of Telix Pharmaceuticals's earnings date in Jul 2, 2026, Telix Pharmaceuticals's earnings has grown year over year. TLX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.